ethyl 2-methyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate, 95+%, 50mg

7-BROMO-1H-INDAZOLE-3-CARBALDEHYDE, 95%, 100mg

2-Chloro-6-methyl-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 5g

Perfluoro-2-butyltetrahydrofuran (mixture of isomers), 95%, 1g

8-methyl-4-(4-methylbenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

3-Amino-4-nitrotoluene, 95.0%, 25g

1-Bromo-2,4,5-trimethylbenzene, 95.0%, 1g

tert-Butyl 4-(1-(4-aminophenyl)piperidine-4-carbonyl)piperazine-1-carboxylate, 100mg

5-Ethoxycarbonyl-4-(trifluoromethyl)-pyrimidin-2-(1H)-one, 85.0%, 10g

Natriumhypochloritlösung, 5-10 % Cl, techn., 10 l, kunststoffverpackung.

Tricaprin, min. 98 %, 10 g, Glasverpackung

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid, 98%, 100mg

3-Ethoxy-5-hydroxybenzaldehyde, 95.0%, 250mg